StockNews.AI
IRTC
StockNews.AI
63 days

iRhythm Technologies, Inc. (NASDAQ: IRTC) Investor Alert: Schubert Jonckheer & Kolbe LLP Investigating Possible Shareholder Claims for False Statements and Insider Trading

1. iRhythm is facing a securities fraud lawsuit over misleading claims. 2. Allegations include overstating Zio AT monitor's effectiveness for high-risk patients. 3. Insiders sold around $18 million in stock during the misleading period. 4. U.S. DOJ is investigating iRhythm's marketing practices. 5. The lawsuit claims caused significant drops in iRhythm's stock price.

5m saved
Insight
Article

FAQ

Why Very Bearish?

Legal challenges usually reduce investor confidence, reflected in historical incidents like Theranos.

How important is it?

The alleged misconduct and ongoing investigations can significantly impact stock performance.

Why Long Term?

Ongoing investigations may impose prolonged pressure on stock value, as seen in past securities cases.

Related Companies

THCNVAXAPRI
, /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises iRhythm Technologies, Inc. investors that the firm is investigating potential legal claims relating to alleged false statements exaggerating the capabilities of iRhythm's wearable Zio AT heart event monitor. Current shareholders are encouraged to contact the firm. On June 3, 2025, Judge Jacqueline Scott Corley of the U.S. District Court for the Northern District of California issued an order allowing key claims in a securities fraud lawsuit against iRhythm and CEO Quentin Blackford to move forward. The lawsuit alleges that between November 2021 and August 2024, iRhythm intentionally misled investors by overstating the accuracy and reliability of its Zio AT monitor and misrepresented its suitability for high-risk patients—causing its stock to trade at inflated prices. Judge Corley found that the complaint sufficiently alleged that the defendants made false and misleading statements with an intent to defraud. During this time, company insiders sold approximately $18 million worth of iRhythm stock. The U.S. Department of Justice is also investigating iRhythm's marketing practices. As the truth came out in a series of disclosures from November 2022 through August 2024, iRhythm's stock price fell significantly. We are investigating potential wrongdoing by iRhythm's directors and officers in connection with these allegations. If you own stock in iRhythm, you may have legal options. Please contact us today at https://www.classactionlawyers.com/irhythm to learn more. About Schubert Jonckheer & Kolbe LLPSchubert Jonckheer & Kolbe represents shareholders, employees, and consumers in class actions against corporate defendants, as well as shareholders in derivative actions against officers and directors. The firm is based in San Francisco and, with the help of co-counsel, litigates cases nationwide. ContactDustin L. SchubertSchubert Jonckheer & Kolbe LLP[email protected]Tel: 415-788-4220 SOURCE Schubert Jonckheer & Kolbe LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News